Uliledlimab

Tax included
Uliledlimab is a potent against CD73 humanized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer.
MedChemExpress 
HY-P99169

Data sheet

Size
Multiple sizes
Reactivity
CD73
Application
Cancer-programmed cell death
CAS
2378407-27-1